Miranda Fidler-Benaoudia

Adjunct Assistant Professor

Cancer Epidemiology and Prevention Research

Adjunct Assistant Professor

Oncology and Community Health Sciences


Contact information


Office: 403-355-3277

Web presence


CEPR Website

Research and teaching

Area of Focus

  • Late-effects after cancer, inequalities

Summary of Research

Dr. Fidler-Benaoudia is a clinical and descriptive cancer epidemiologist in the Department of Cancer Epidemiology and Prevention Research. Her research focuses primarily on describing the burden of adolescent and young adult cancers and evaluating their related late- effects. 

She is additionally interested in sub-populations, such as indigenous peoples and childhood cancer survivors, and continues to undertake research comprehensively describing cancer indicators nationally, regionally, and at global levels.


Prior to joining the CEPR, Dr. Fidler-Benaoudia received her bachelor and master degrees from Boston University and University College London, respectively. She then pursued a PhD within the Centre for Childhood Cancer Survivor Studies at the University of Birmingham where she utilized the British Childhood Cancer Survivor Study, Teenage and Young Adult Cancer Survivor Study, and PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies to assess a wide range of late-effects among cancer survivors diagnosed before age 40. Upon completion of her PhD, Dr. Fidler-Benaoudia joined the Section of Cancer Surveillance at the International Agency for Research on Cancer (IARC); here she led research efforts on assessing the burden of cancer according to human development level, and began the first studies quantifying the burden of cancer in adolescents and young adults globally. She was also involved in other projects, such as benchmarking cancer survival in high-income (International Cancer Benchmarking Partnership) and low- and middle-income countries (SURVCAN-3), undertaking descriptive trend analyses for specific cancers and regions, and reviewing social inequalities in cancer for an IARC scientific publication.